Registry to Improve the Adoption of Consensus Treatment Guidelines (IMPROVE Brady) (IMPROVE Brady)
Sponsor: Medtronic Cardiac Rhythm and Heart Failure
A observational or N/A phase clinical study on Sinus Node Dysfunction, this trial is completed. The trial is conducted by Medtronic Cardiac Rhythm and Heart Failure and has accumulated 14 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
14 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2023 — Jul 2024 [monthly]
Completed
-
Dec 2022 — Jan 2023 [monthly]
Completed
▶ Show 9 earlier versions
-
Dec 2021 — Dec 2022 [monthly]
Completed
-
Oct 2021 — Dec 2021 [monthly]
Completed
-
Jan 2021 — Oct 2021 [monthly]
Completed
-
Apr 2020 — Jan 2021 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Nov 2018 — Apr 2020 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Jun 2018 — Nov 2018 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Oct 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — Oct 2017 [monthly]
Recruiting NA
First recorded
Jul 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Medtronic Cardiac Rhythm and Heart Failure
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Ahmedabad, India , Amur, Russia , Arequipa, Peru , Bangalore, India , Buenos Aires, Argentina , Chelyabinsk, Russia , Chennai, India , Delhi, India , Dhaka, Bangladesh , Durgapur, India and 7 more locations